NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
JohnsonLGMadeleineMMNewcomerLM. Anal cancer incidence and survival: the Surveillance, Epidemiology, and End Results experience, 1973–2000. Cancer2004;101:281–288.
DalingJRMadeleineMMJohnsonLG. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer2004;101:270–280.
JimenezWPaszatLKupetsR. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol2009;114:395–398.
SunesenKGNorgaardMThorlacius-UssingOLaurbergS. Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978–2005. Int J Cancer2010;127:675–684.
FrischMBiggarRJGoedertJJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst2000;92:1500–1510.
De VuystHCliffordGMNascimentoMC. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer2009;124:1626–1636.
HootsBEPalefskyJMPimentaJMSmithJS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer2009;124:2375–2383.
PalefskyJMHollyEARalstonMLJayN. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis1998;177:361–367.
PatelPHansonDLSullivanPS. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med2008;148:728–736.
BerryJMPalefskyJMJayN. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum2009;52:239–247.
ParkIUPalefskyJM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep2010;12:126–133.
RoarkR. The need for anal dysplasia screening and treatment programs for HIV-infected men who have sex with men: a review of the literature. J Assoc Nurses AIDS Care2011;22:433–443.
DillnerJKjaerSKWheelerCM. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ2010;341:c3493.
GarlandSMHernandez-AvilaMWheelerCM. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med2007;356:1928–1943.
PalefskyJMGiulianoARGoldstoneS. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med2011;365:1576–1585.
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep2010;59:626–629.
KreimerARGonzalezPKatkiHA. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol2011;12:862–870.
AjaniJAWinterKAGundersonLL. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA2008;299:1914–1921.